Francesca Galvani

Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency

M. Mor, A. Lodola, S. Rivara, 2022, J. Chem. Inf. Model..

Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions.

M. Mor, S. Gemma, G. Campiani, 2022, European journal of medicinal chemistry.

Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations

M. Mor, A. Rizzi, Alberto Cuzzolin, 2023, J. Chem. Inf. Model..

Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents

M. Mor, V. Moliner, S. Martí, 2023, J. Chem. Inf. Model..

Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: a successful application of target hopping approach.

M. Mor, V. Ballabeni, E. Barocelli, 2023, Biochemical pharmacology.

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

M. Tiseo, P. Petronini, L. Flammini, 2024, Scientific reports.

Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines.

M. Tiseo, C. Fumarola, M. Bonelli, 2024, Biochemical pharmacology.